Top

Inflammopharmacology

Published in:

01-08-2018 | Book Review

W.E.W. Roediger: Causative factors of ulcerative colitis and Crohn’s disease: an exploratory guide

Wakefield Press 2016 (reprinted 2017). 106 pp. ISBN 978 174305 433 8

Author: Michael W. Whitehouse

Published in: Inflammopharmacology | Issue 4/2018

Abstract

This monograph provides the background for new developments in gastroenterological pharmacology, particularly focussing on the two chronic inflammatory bowel diseases, ulcerative colitis (UC) and Crohn’s disease (CD). These currently cause significant morbidity but largely elude satisfactory treatment. This is a challenge to drug designers and experimental physiologists alike. Their efforts will be much enhanced by further understanding the aspects of molecular pathogenesis and physiological dysregulation outlined in this valuable and timely survey.

Available only for authorised users

Davies NM (1995) Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 38:1311–1321CrossRefPubMed

Dixon MF (2009) Chronic inflammatory disorders (Alimentary tract). In: Underwood JCE, Cross SS (eds) General and systemic pathology, 5th edn. Churchill Livingstone, Edinburgh, pp 385–390

Evans AS (1993) Causation and disease. A chronological journey. Plenum Medical Book Co., New York, p 238CrossRef

Giampaolo C, Gray AT, Olshen RA, Szabo S (1991) Predicting chemically induced duodenal ulcer and adrenal necrosis with classification trees. Proc Natl Acad Sci 88:6298–6302CrossRefPubMed

Holmes ESL (2017) Heal your gut. Murdoch Books (Allen & Unwin), London

Jacobs G, Kjaer J (1997) Beat Candida through diet. A complete dietary program for sufferers of Candidiasis. Vermilion (Random House), London

Lindsay R, Gregory MS, Yazbek R, Butler RN, Howarth GN (2010) Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis. Br J Nutr 104:513–519CrossRefPubMed

Maier L, Pruteanu M, Kuhn M, Zeiler G, Telzerow A, Anderson EE et al (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. https://doi.org/10.1038/nature25979) CrossRefPubMedPubMedCentral

Peters RA (1963) Biochemical lesions and lethal synthesis. Pergamon Press, Oxford, p 321

Rouch JD, Scott A, Lei NY, Solorzano-Vargas RS, Wang J, Hanson EM et al (2015) Development of functional microfold (M) cells from intestinal stem cells in primary human enteroids. PLoS One 11:e0148216CrossRef

Rubin J, Remedios D (2005) The great physician’s Rx for Health & Wellness. Nashville TN. Nelson Books, pp 370 (The first author, aged 19, was totally incapacitated with CD, failed to respond to allopathic and other prescribed treatments but regained full-health through nutritional medicine)

Sisson G, Bjarnason I (2011) Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents. Inflammopharmacol 19:183–186CrossRef

Svartz N (1942) Salazopyrin, a new sulfanilamide preparation. A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. J Int Med 110:577–598

Thomas GAO, Rhodes J, Green JT, Richardson C (2000) Role of smoking in inflammatory bowel disease: implication for therapy. Postgrad Med J 76:273–279CrossRefPubMedPubMedCentral

Turner A, Hancock G, Wells J, Whitehouse M (2015) Traditional medicinal oils sourced from birds.: anti-inflammatories and potential immunoregulants. Progr Drug Res 70:155–178

Vitetta L, Briskey D, Alford H, Hall S, Coulson S (2014a) Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology 22:135–154CrossRefPubMed

Vitetta L, Manuel R, Zhou J, Linnane A, Hall S, Coulson S (2014b) The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures. Pharmaceuticals 7:954–989CrossRefPubMedPubMedCentral

Whitehouse MW (1964) Some biochemical and pharmacological properties of anti-inflammatory drugs. Progr Drug Res 8:321–429

Whitehouse MW (1982) Rat polyarthritis: induction with adjuvants composed of various mycobacteria (and oils) from the environment. J Rheumatol 9:494–501PubMed

Title: W.E.W. Roediger: Causative factors of ulcerative colitis and Crohn’s disease: an exploratory guide
Wakefield Press 2016 (reprinted 2017). 106 pp. ISBN 978 174305 433 8
Author: Michael W. Whitehouse
Publication date: 01-08-2018
Publisher: Springer International Publishing
Published in: Inflammopharmacology / Issue 4/2018
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-018-0491-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

W.E.W. Roediger: Causative factors of ulcerative colitis and Crohn’s disease: an exploratory guide

Wakefield Press 2016 (reprinted 2017). 106 pp. ISBN 978 174305 433 8

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Silver oxide nanoparticles alleviate indomethacin-induced gastric injury: a novel antiulcer agent

Anti-inflammatory, anti-rheumatic and analgesic activities of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-N-propylbenzenesulphonamide (MOPBS) in rodents

Does the administration of melatonin during post-traumatic brain injury affect cytokine levels?

Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data

Effect of early natal supplementation of paracetamol on attenuation of exotoxin/endotoxin induced pyrexia and precipitation of autistic like features in albino rats

Pharmacological mechanisms underlying gastroprotective activities of binapthyl diselenide in Wistar rats